Health products policy and standards
Our team provides authoritative guidance and standards on quality, safety and efficacy of health products and supports countries to formulate evidence-based policies and ensure good practice throughout the value chain.
Working documents in public consultation
Please provide any comments you may have as per the instructions indicated in the text box on the first page of each working document. Comments should be submitted through the PleaseReviewTM online platform which facilitates document review, co-authoring and redaction. To register on this PleaseReview platform, please contact nsp@who.int. You may use the Table for comments template if you are unable to access the PleaseReview platform.
- Good practices for regulatory oversight of the disposal of medical products throughout their life cycle (QAS/26.1006)
- Points to Consider on Integration of Environmental Sustainability Strategies and Metrics into Pharmaceutical Manufacturing (QAS26.998)
- Bioequivalence for Immediate Release Oral Dosage Form (QAS25.990)
- Model quality assurance system for procurement agencies (QAS25.983)
New working documents under review for norms and standards for pharmaceuticals
Monographs and general texts under review/revision for inclusion in The International Pharmacopoeia
for inclusion in the International Pharmacopoeia
- Dapsone Tablets (Dapsoni Compressi)_QAS/23.920
- Dapsone (Dapsonum)_QAS/23.919
- Cefiderocol powder for concentrate for solution for infusion (QAS/24.968)
- Cefiderocol Sulfate Tosilate (QAS/24.967)
- Tenofovir Alafenamide Fumarate (QAS25-989)
- Draft revision of chapter 2.11: Micro determination of water by the Karl Fischer Method (QAS/25.986)
- DIETHYLCARBAMAZINE DIHYDROGEN CITRATE (QAS/21.896)
- Gliclazide (QAS25.976 FPC)
- Gliclazide sustained release tablets (QAS25.975 FPC)
- Cefiderocol powder for concentrate for solution for infusion (QAS24.968 FPC)
- Cefiderocol sulfate tosilate (QAS24.967 FPC)
- Ethambutol Dihydrochloride tablets (Ethambutoli Dihydrochloridi compressi) (QAS/24.960)
- Aminosalicylate Sodium delayed-release tablets (Aminosalicylati Natrii compressi ad tardatam liberationem) (QAS/20.845)
- Aminosalicylate Sodium Dihydrate (Aminosalicylatum Natricum Dihydricus) (QAS/20.844)